Devesh Ramnath, MD
Orthopaedic Surgery · Dallas, TXNPI 1871580621
Payments from drug & device makers
Across 44 payments — averaging $117.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Innovasis Inc$2K
- Medical Device Business Services, Inc.$1K
- Johnson & Johnson$348
- Orthofix Medical, Inc.$285
- Abbott$241
- Amgen$114
- plus $270 from 6 others
What the payments were for
- Travel & lodging$3,24863%
- Food & beverage$1,71733%
- Education$2124%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Innovasis Inc | 2 | $2,474 |
| Medical Device Business Services, Inc. | 10 | $1,445 |
| Johnson & Johnson(2 entities) | 7 | $348 |
| Orthofix Medical, Inc. | 3 | $285 |
| Abbott | 4 | $241 |
| Amgen | 8 | $114 |
| Medtronic | 4 | $101 |
| Globus Medical | 2 | $79 |
| Si-bone, Inc. | 1 | $38 |
| Stryker | 1 | $24 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
| Bioventus LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CONCORDE$1,025
- VIPER$1,025
- PROCLAIM$170
- SYMPHONY$153
- Expedium VERSE$153
- M6-C$139
- Mariner Deformity$117
How this compares
$5,177 in reported general payments places this provider in the 50th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Baclofen | 312 | $3,891 |
| Gabapentin | 511 | $3,878 |
| Celecoxib | 208 | $2,542 |
| Tizanidine Hcl | 40 | $1,356 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 98 | $1,233 |
| Cyclobenzaprine Hcl | 103 | $1,063 |
| Naproxen | 111 | $763 |
| Pregabalin | 53 | $697 |
| Ondansetron OdtOndansetron | 30 | $430 |
| Methocarbamol | 41 | $423 |
| Meloxicam | 126 | $404 |
| Methylprednisolone | 55 | $330 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $182 |
| Diclofenac Sodium | 13 | $182 |
| Ibuprofen | 15 | $130 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Dallas
- Richard JonesDallas$6.3M
- James BrodskyDallas$2.5M
- Sumant KrishnanDallas$1.9M
- Wayne BurkheadDallas$1.2M
- Kevin KruseDallas$824K
- Daniel WorrelDallas$741K
- Bradford WaddellDallas$442K
- Jay MabreyDallas$310K
- Stephen BurkhartSan Antonio$185.3M
- Kirby HittTemple$9.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.